Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes

Allogeneic hematopoietic stem cell transplantation (HCT) is the only curative treatment for myelodysplastic syndrome (MDS). The proportion of MDS patients referred for transplant evaluation, those undergoing transplantation and the reasons for not undergoing transplant are unknown. In this retrospec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Getta, Bartlomiej M., Kishtagari, Ashwin, Hilden, Patrick, Tallman, Martin S., Maloy, Molly, Gonzales, Patrick, Castro-Malaspina, Hugo, Perales, Miguel-Angel, Giralt, Sergio, Tamari, Roni, Klimek, Virginia
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386429/
https://ncbi.nlm.nih.gov/pubmed/28336325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.03.020
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items